Magnesium-containing compositions and methods for enhancing dehydroepiandrosterone levels
OwnerC. Shealyinventor
Life of this patent
Estimating the term…
Abstract
Compositions and methods for using the same to restore dehydroepiandrosterone (DHEA) levels in humans are described. The compositions comprise magnesium chloride, a suitable solvent, a gelling agent and a glycerin. The compositions are administered to the skin of humans to enhance DHEA levels through the transdermal absorption of magnesium. The compositions can be administered in various forms, including as a lotion, an ointment, or as a bath additive.
Claims17
A method of raising serum DHEA levels in an individual, the method comprising applying a therapeutically effective amount of a magnesium-containing composition to the individual's skin, the magnesium-containing composition comprising about 25 to 35 weight percent magnesium chloride, a solvent, a gelling agent and glycerin.
A method of raising serum DHEA levels in an individual, the method comprising applying a therapeutically effective amount of a magnesium-containing composition to the individual's skin, the magnesium-containing composition comprising about 25 to 35 weight percent magnesium chloride, about 60 to 75 weight percent water, about 0.1 to 5 weight percent methyl cellulose and about 0.1 to 5 weight percent glycerin.
A composition for the transdermal absorption of magnesium comprising:
- (a) about 25 to 35 weight percent magnesium chloride;
- (b) about 60 to 75 weight percent water;
- (c) about 0.1 to 5 weight percent of a gelling agent;
- and
- (d) about 0.1 to 5 weight percent glycerin.
Dependencies are inferred from the claim text.